TUESDAY, Feb. 28, 2023 (HealthDay News) — When Black patients struggle with dementia, they are less likely to receive helpful medications than their white peers, a new study warns. Researchers looked at how often patients received one or more of five classes of medications commonly given to dementia patients livingContinue Reading

TUESDAY, Feb. 28, 2023 (HealthDay News) — Pedestrian deaths have surged on U.S. roads in recent years, and they are climbing again. Pedestrian deaths hit a 40-year high in 2021, and numbers for the first half of 2022 were up about 5% over the same period in 2021, according toContinue Reading

FRIDAY, Feb. 24, 2023 (HealthDay News) — The U.S. Food and Drug Administration’s heavily criticized tobacco program promised changes on Friday, including a five-year strategic plan to better outline priorities. “As we enter this era of declining use of combustible tobacco and continued innovation in the e-cigarette industry, the societalContinue Reading

THURSDAY, Feb. 23, 2023 (HealthDay News) — America’s health care workforce is under unprecedented strain, and leaders of the medical profession are scrambling to shore up doctors and nurses who are burning out in record numbers. Nearly two-thirds (63%) of a nationwide group of doctors and nurses said they areContinue Reading

WEDNESDAY, Feb. 22, 2023 (HealthDay News) — A gene variant found almost exclusively among people of African descent appears to substantially raise the risk of Alzheimer’s disease, a new study finds. The variant is in a gene called ApoE3, and it’s apparently only harmful when it exists in combination withContinue Reading

WEDNESDAY, Feb. 15, 2023 (HealthDay News) — A nasal spray that can reverse an opioid overdose may become available for easier over-the-counter purchase. U.S. Food and Drug Administration advisers are meeting Wednesday to discuss making generic naloxone hydrochloride available without requiring interaction with a pharmacist, CNN reported. Approval could happenContinue Reading